dataset chembl (Biogen Inc)
86
Structured Review
Biogen Inc
dataset chembl
Dataset Chembl, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biogen-idec/biogen+dataset+model+single/pmc13170136-210-19-31
Average 86 stars, based on 1 article reviews
Dataset Chembl, supplied by Biogen Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biogen-idec/biogen+dataset+model+single/pmc13170136-210-19-31
Average 86 stars, based on 1 article reviews
dataset chembl - by Bioz Stars,
2026-10
86/100 stars
Images
1) Product Images from "Assessing the impact of data harmonization on human liver microsomal stability prediction model performance"
Article Title: Assessing the impact of data harmonization on human liver microsomal stability prediction model performance
Journal: Results in chemistry
doi: 10.1016/j.rechem.2026.103305
Figure Legend Snippet: Visualization of chemical space diversity using a t-SNE plot of RDKit molecular descriptors for Biogen (green), ChEMBL (teal), NCATS (purple), AstraZeneca (orange), Polaris (magenta). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Techniques Used:
Related Articles
Clinical Proteomics:Article Title: Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study) Article Snippet: MS: received travel funding and/or Article Title: De-escalating and discontinuing disease-modifying therapies in multiple sclerosis Article Snippet: J.O. has received grant funding from Article Title: The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study Article Snippet: Article Title: De-escalating and discontinuing disease-modifying therapies in multiple sclerosis Article Snippet: C.E. has received personal Article Title: Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort. Article Snippet: Article Title: Hallmarks of primary headache: part 2– Tension-type headache Article Snippet: Wu has received Article Title: Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions. Article Snippet: Background: Age of symptom onset may affect health-related quality of life (HrQoL) in multiple sclerosis (MS).. Objective: To evaluate if age of MS symptom onset affects HrQoL in adulthood.. Methods: Participants from the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo) were assessed annually (2019–2022) using the MS Quality of Life-54 (MSQoL-54), which measures physical and mental health, with higher scores indicating better HrQoL. Article Title: The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.lanepe.2025.. 101302 The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational study Carmen Tur,a,∗ Pere Carbonell-Mirabent, Susana Otero-Romero, Álvaro Cobo-Calvo, María Jesús Arévalo, Helena Ariño, Georgina Arrambide, Cristina Auger, René Carvajal, Joaquín Castilló, Manuel Comabella, Ingrid Galán, Luciana Midaglia, Carlos Nos, Agustín Pappolla, Deborah Pareto, Jordi Río, Breogán Rodríguez-Acevedo, Estibaliz Saez de Gordoa, Ángela Vidal-Jordana, Ana Zabalza, Jaume Sastre-Garriga, Àlex Rovira, Xavier Montalban, and Mar Tintoré |